TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18401809

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 30 Hz and 4 mm amplitude for 60 seconds, repeated twice
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 23
Study: 15890314

Group type: EXPERIMENTAL
Intervention: Cognitive behaviourally based stress management intervention (SMI) group
Number of subjects: 209

Group type: COMPARATOR
Intervention: Non‐intervention control group
Number of subjects: 209
Study: 16091231

Group type: EXPERIMENTAL
Intervention: New antiretroviral drugs used carefully with an active background regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance testing and drug level monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-drug regimens
Number of subjects: 0
Study: 11690728

Group type: EXPERIMENTAL
Intervention: Pregabalin (exact dosage not specified)
Number of subjects: 2724

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2724
Study: 9325520

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (Cytotec)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gemeprost (Cervagem)
Number of subjects: 50
Study: 7705375

Group type: EXPERIMENTAL
Intervention: Spinal degenerative calcification
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Aortic calcification
Number of subjects: 115
Study: 3601047

Group type: EXPERIMENTAL
Intervention: Left visual half-field presentation of dot arrays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Right visual half-field presentation of dot arrays
Number of subjects: 0
Study: 29861267

Group type: COMPARATOR
Intervention: Physical activity (PA) recommendations and sedentary behavior
Number of subjects: 67

Group type: COMPARATOR
Intervention: Peak oxygen uptake
Number of subjects: 67
Study: 27598553

Group type: EXPERIMENTAL
Intervention: Proprioceptive/strengthening exercises combined with manual therapy (mobilizations to influence joint and nerve structures)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Proprioceptive/strengthening exercises
Number of subjects: 56
Study: 24866273

Group type: EXPERIMENTAL
Intervention: Regular physiotherapy (baseline)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Blocks of physiotherapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Regular physiotherapy
Number of subjects: 39
Study: 23538020

Group type: EXPERIMENTAL
Intervention: Ezetimibe added to maximum tolerated statin therapy
Number of subjects: 2287

Group type: COMPARATOR
Intervention: Maximum tolerated statin therapy without ezetimibe
Number of subjects: 2287
Study: 20655105

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg per day
Number of subjects: 17802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17802
Study: 18211506

Group type: EXPERIMENTAL
Intervention: Steroid-free group (n = 112)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal group (n = 115)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Standard steroids group (n = 109)
Number of subjects: 336
Study: 16984076

Group type: EXPERIMENTAL
Intervention: Multiple-family group treatment (MFGT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 97
Study: 14573327

Group type: EXPERIMENTAL
Intervention: More intensive comprehensive educational‐behavioral‐pharmacologic intervention
Number of subjects: 309

Group type: COMPARATOR
Intervention: Less intensive education and referral intervention
Number of subjects: 309
Study: 10920067

Group type: EXPERIMENTAL
Intervention: Carvedilol (49±18 mg/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Metoprolol (124±55 mg/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both metoprolol and carvedilol
Number of subjects: 150
Study: 8756930

Group type: EXPERIMENTAL
Intervention: Whitacre needle
Number of subjects: 340

Group type: COMPARATOR
Intervention: Quincke needle
Number of subjects: 340
Study: 1551312

Group type: EXPERIMENTAL
Intervention: Intravenous metformin infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: NaCl infusion (control)
Number of subjects: 9
Study: 3551340

Group type: EXPERIMENTAL
Intervention: Forskolin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fenoterol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30113051

Group type: EXPERIMENTAL
Intervention: Probiotic supplements (8 × 10^9 CFU day‐1) for 12 weeks
Number of subjects: 60
Study: 27443982

Group type: EXPERIMENTAL
Intervention: Presence of children in the home
Number of subjects: 556
Study: 24668063

Group type: EXPERIMENTAL
Intervention: Essential oil mixture applied topically three times a day until 1 month postradiation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care (RadiaPlexRx™ ointment) applied topically three times a day until 1 month postradiation
Number of subjects: 24
Study: 22341740

Group type: EXPERIMENTAL
Intervention: 24-week training program (controlled physical training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training program (control group)
Number of subjects: 0
Study: 19945545

Group type: EXPERIMENTAL
Intervention: Thyroid hormone supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thyroid hormone supplementation in brain stem death setting
Number of subjects: 0
Study: 18377122

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 108
Study: 15693930

Group type: EXPERIMENTAL
Intervention: Valdecoxib 20 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 550 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12633121

Group type: EXPERIMENTAL
Intervention: Risperidone (mean dose 0.95 mg/day)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345
Study: 14528573

Group type: EXPERIMENTAL
Intervention: Help card and letter sent to patients before their appointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients who did not receive the help card)
Number of subjects: 0
Study: 7859137

Group type: EXPERIMENTAL
Intervention: Shorter health status assessment scales (21 items)
Number of subjects: 1934

Group type: COMPARATOR
Intervention: Longer health status assessment scales (38 items)
Number of subjects: 1934
Study: 1782307

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7460480

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg three times a day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31237644

Group type: EXPERIMENTAL
Intervention: 1 month of DAPT followed by clopidogrel monotherapy
Number of subjects: 3045

Group type: COMPARATOR
Intervention: 12 months of DAPT with aspirin and clopidogrel
Number of subjects: 3045
Study: 29228964

Group type: EXPERIMENTAL
Intervention: Probiotics (2.5 × 10^9 cfu/g) containing Bifidobacterium bifidum W23, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19 and Lactococcus lactis W58 (Ecologic®Barrier)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 26387049

Group type: EXPERIMENTAL
Intervention: Alcohol-Adapted Anger Management Treatment (AM)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Alcoholics Anonymous Facilitation treatment (AAF)
Number of subjects: 76
Study: 25022131

Group type: EXPERIMENTAL
Intervention: Needle-knife therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture-cupping
Number of subjects: 60
Study: 22115970

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention consisting of self-management training delivered over a 24-month period
Number of subjects: 144

Group type: COMPARATOR
Intervention: Bilingual newsletter providing identical information
Number of subjects: 144
Study: 18771430

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 191

Group type: COMPARATOR
Intervention: Iopromide
Number of subjects: 191
Study: 18322604

Group type: EXPERIMENTAL
Intervention: bicyclol combined with thymosin
Number of subjects: 135
Study: 15010365

Group type: EXPERIMENTAL
Intervention: Alendronate (40 mg/d)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: Alendronate and Placebo
Number of subjects: 34
Study: 11588457

Group type: EXPERIMENTAL
Intervention: PGE1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 10918156

Group type: EXPERIMENTAL
Intervention: Microwave coagulation therapy (14 patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hepatectomy (16 patients)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Microwave coagulation therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hepatectomy
Number of subjects: 30
Study: 8791968

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg nightly
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Cimetidine > or = 2 g daily
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Cimetidine (general treatment)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Malignant disease
Number of subjects: 74
Study: 1639051

Group type: EXPERIMENTAL
Intervention: High PUFA diet (20% energy; SAFA and MUFA 10% each)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High MUFA diet (20% energy; SAFA and PUFA 10% each)
Number of subjects: 28

Group type: COMPARATOR
Intervention: High SAFA diet
Number of subjects: 28
Study: 6208573

Group type: EXPERIMENTAL
Intervention: Verbal advance organizer presented to experimental subjects at the beginning of each of six classes.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Nonorganizing historical information presented to control subjects at the beginning of each of six classes.
Number of subjects: 43
Study: 31284871

Group type: EXPERIMENTAL
Intervention: Intravenous Ketamine (0.3 mg/kg)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Intravenous Morphine (0.1 mg/kg)
Number of subjects: 135
Study: 29696307

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional fluoroscopic technique
Number of subjects: 30
Study: 26395786

Group type: EXPERIMENTAL
Intervention: Cellphone reminder/recall (R/R)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Primary Health Care Immunization Providers' Training (PHCIPT)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Combined cellphone R/R and PHCIPT
Number of subjects: 595

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 595
Study: 24509055

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 22421738

Group type: EXPERIMENTAL
Intervention: Anticoagulation with fondaparinux sodium
Number of subjects: 64

Group type: COMPARATOR
Intervention: Anticoagulation with fondaparinux sodium + vena cava filter
Number of subjects: 64
Study: 20201005

Group type: EXPERIMENTAL
Intervention: Carisbamate 400 mg/day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 18351423

Group type: EXPERIMENTAL
Intervention: Minimally invasive TKA (MIS-TKA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 30
Study: 16471172

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 39

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 39

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 39
Study: 12742806

Group type: EXPERIMENTAL
Intervention: Fasting triglyceride levels
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Nonfasting triglyceride levels
Number of subjects: 2809
Study: 10505300

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.05‐0.8 mg orally, given as single or multiple once‐daily doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerivastatin with a high‐fat meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerivastatin administered at different times (morning, evening meal, bedtime)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marketed tablet strengths and drug formulations from different sources
Number of subjects: 0
Study: 8605793

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 0.1 mg/kg (n = 3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 0.33 mg/kg (n = 3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 1.0 mg/kg (n = 3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787
Number of subjects: 9
Study: 1709039

Group type: EXPERIMENTAL
Intervention: Spantide (substance P antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no substance P antagonist)
Number of subjects: 0
Study: 31711430

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention including three antenatal counselling sessions on diet and physical activity and one postpartum session
Number of subjects: 2101

Group type: COMPARATOR
Intervention: Control group receiving usual care
Number of subjects: 2101

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2101
Study: 29590461

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study: 27688117

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electro cautery (EC)
Number of subjects: 40
Study: 25350851

Group type: COMPARATOR
Intervention: RV144 vaccine
Number of subjects: 110
Study: 22594098

Group type: EXPERIMENTAL
Intervention: True acupuncture (20 sessions for approximately one and a half months)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Sham acupuncture (control group 1)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Routine care (control group 2)
Number of subjects: 87
Study: 19672550

Group type: EXPERIMENTAL
Intervention: Formula with 225 mcg/l lutein
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Formula with 120 mcg/l lutein
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Formula with 45 mcg/l lutein
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unfortified formula (20 mcg/l lutein)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Breastfed infants
Number of subjects: 40
Study: 17917517

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 16193896

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 800 mg/m2 plus methylprednisolone 1 g IV (CY/MP)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Methylprednisolone once a month for six months (MP)
Number of subjects: 59
Study: 11831539

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of amifostine (500 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral administration of amifostine (500 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous infusion of amifostine (200 mg/m2)
Number of subjects: 12
Study: 10427933

Group type: EXPERIMENTAL
Intervention: Oral iodized oil (OIO)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Placebo (poppy-seed oil)
Number of subjects: 617
Study: 7553231

Group type: EXPERIMENTAL
Intervention: 3 million units of subcutaneously injected recombinant IFN‐alpha 2b three times per week for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific treatment)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 3 million units of subcutaneously injected recombinant IFN‐alpha 2b
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low pretreatment levels of HCV RNA
Number of subjects: 50
Study: 2142699

Group type: EXPERIMENTAL
Intervention: L-tyrosine, 100 mg/kg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Imipramine, 2.5 mg/kg/day
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 7024155

Group type: EXPERIMENTAL
Intervention: Conventional 1000 kcal diet with diethylpropion permitted
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isocaloric partial meal replacement with protein powder, and diethylpropion permitted
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-meal satiation with protein powder
Number of subjects: 0
Study: 31931928

Group type: EXPERIMENTAL
Intervention: Minimally invasive percutaneous lag screw internal fixation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Reconstruction plate
Number of subjects: 130
Study: 30303746

Group type: EXPERIMENTAL
Intervention: Ketotifen 0.025%
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ketotifen 0.05%
Number of subjects: 81
Study: 28085735

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 12
Study: 26424589

Group type: EXPERIMENTAL
Intervention: Gastrointestinal microbiome modulator (GIMM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24844352

Group type: EXPERIMENTAL
Intervention: Behavioral urotherapy combined with pelvic floor muscle (PFM) exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Behavioral urotherapy
Number of subjects: 60
Study: 22946066

Group type: EXPERIMENTAL
Intervention: Pre-call intervention delivered to all babies at aged four weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 19875843

Group type: EXPERIMENTAL
Intervention: 15 minutes of immobilisation after intrauterine insemination
Number of subjects: 391

Group type: COMPARATOR
Intervention: Immediate mobilisation after insemination (control)
Number of subjects: 391
Study: 16878429

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.i.d. for 16 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12681885

Group type: EXPERIMENTAL
Intervention: Low-dose monophasic oral contraceptives
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (women not using oral contraceptives)
Number of subjects: 12
Study: 10823361

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2% BID
Number of subjects: 40

Group type: COMPARATOR
Intervention: Latanoprost 0.005% QD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Brimonidine with concomitant pilocarpine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Latanoprost with concomitant pilocarpine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Brimonidine with concomitant dorzolamide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Latanoprost with concomitant dorzolamide
Number of subjects: 40
Study: 8888663

Group type: EXPERIMENTAL
Intervention: Spironolactone 12.5 mg
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Spironolactone 75 mg
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 2001757

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound-guided embryo transfer
Number of subjects: 94

Group type: COMPARATOR
Intervention: Traditional blind embryo transfer technique
Number of subjects: 94
Study: 6872169

Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 120 mg verapamil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (5 to 30 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31076421

Group type: EXPERIMENTAL
Intervention: Wolffia globosa Mankai shake
Number of subjects: 20
Study: 28645983

Group type: EXPERIMENTAL
Intervention: slow-release Mg hydroxide 30 mmol/day
Number of subjects: 250

Group type: COMPARATOR
Intervention: matching placebo
Number of subjects: 250
Study: 25890643

Group type: COMPARATOR
Intervention: Pomaglumetad 40 mg BID
Number of subjects: 206

Group type: COMPARATOR
Intervention: Pomaglumetad 80 mg BID
Number of subjects: 206

Group type: COMPARATOR
Intervention: Risperidone 2 mg BID
Number of subjects: 206
Study: 23146549

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control
Number of subjects: 400
Study: 21383219

Group type: EXPERIMENTAL
Intervention: SCID interview
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: PHQ-9 survey
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: PHQ-9 score elevations (≥15)
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: PHQ-9 scores
Number of subjects: 506
Study: 18645513

Group type: EXPERIMENTAL
Intervention: Safer Sex Skills Building (SSB) groups, five 90-minute sessions focusing on problem solving and skills rehearsal.
Number of subjects: 515

Group type: COMPARATOR
Intervention: Standard HIV/STD Education (HE), one 60-minute session covering disease, testing, treatment, and prevention information.
Number of subjects: 515
Study: 16615668

Group type: EXPERIMENTAL
Intervention: Spirulina extract (250 mg) plus zinc (2 mg) twice daily for 16 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Spirulina extract plus zinc
Number of subjects: 41
Study: 14718876

Group type: EXPERIMENTAL
Intervention: Plasma arc curing light (Apollo 95E)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional curing unit (Ortholux XL 3000)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 45
Study: 11167866

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 583

Group type: COMPARATOR
Intervention: Open appendicectomy
Number of subjects: 583